| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:637.)
© 2003 American Heart Association, Inc.
Original Contributions |
From the Department of Neurosurgery (A.K.), University of Glasgow, Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK; the Department of Neuroimmunology (A.P., G.K., E.T.), University of London, Institute of Neurology and Neurosurgery, Queen Square, London, UK; Center for Nursing Research, University of Pittsburgh (M.K.), Pittsburgh, Pa; and the Division of Clinical Neurosciences (J.N.), University of Southampton, Southampton General Hospital, Southampton, UK.
Correspondence to Andrew Kay, University of Glasgow, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, UK. E-mail adk4z{at}clinmed.gla.ac.uk
Background and Purpose The apolipoprotein E (APOE)
4 allele has been associated with unfavorable outcome after subarachnoid hemorrhage (SAH), suggesting that apoE plays an important role in the response of the brain to SAH. We determined the concentration of apoE in the cerebrospinal fluid (CSF) of patients with SAH and a control group to test the hypothesis that alterations in CSF apoE reflect the response of the brain to SAH and are correlated with the severity of injury and outcome.
Methods ApoE and S100B (a marker of brain injury) were measured by ELISA in CSF from a nonbrain-injured control group and patients with SAH. The severity of SAH was determined from the Glasgow Coma Scale, and the clinical outcome was determined from the Glasgow Outcome Scale.
Results In contrast to increased CSF concentration of S100B, CSF apoE concentration was significantly lower in patients after SAH than in control subjects (Mann-Whitney test, P<0.0001). SAH patients with more severe injury and less favorable outcome had lower CSF apoE concentration than did patients with milder injury and better clinical outcome (Fisher exact test, P=0.02).
Conclusions The concentration of apoE in the CSF decreases after SAH, despite the likely leakage of plasma apoE into the CSF. We speculate that apoE is retained within the parenchyma of the central nervous system in response to injury, where, in view of previous data, it may have a protective role.
Key Words: apolipoproteins cerebrospinal fluid outcome subarachnoid hemorrhage
This article has been cited by other articles:
![]() |
L. A. Lanterna, Y. Ruigrok, S. Alexander, J. Tang, F. Biroli, L. T. Dunn, and W. S. Poon Meta-analysis of APOE genotype and subarachnoid hemorrhage: Clinical outcome and delayed ischemia Neurology, August 21, 2007; 69(8): 766 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Petzold, G Keir, A Kay, M Kerr, and E J Thompson Axonal damage and outcome in subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry, June 1, 2006; 77(6): 753 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Macdonald Advances in Vascular Surgery Stroke, February 1, 2004; 35(2): 375 - 380. [Full Text] [PDF] |
||||
![]() |
A. Kay, A. Petzold, M. Kerr, G. Keir, E. Thompson, and J. Nicoll Temporal Alterations in Cerebrospinal Fluid Amyloid {beta}-Protein and Apolipoprotein E After Subarachnoid Hemorrhage Stroke, December 1, 2003; 34 (12): e240 - e243. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |